Reading UTHR? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track UTHR free→Reading UTHR? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track UTHR free→QuarterlyIQ Insights · UTHR
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Results of Operations and Financial Condition. On May 6, 2026, United Therapeutics Corporation issued a press release setting forth its earnings for the quarter ended March 31, 2026. A copy of the press release is attached hereto as Exhibit 99.1.
Entry into a Material Definitive Agreement. On March 8, 2026, the Board of Directors (the Board ) of United Therapeutics Corporation (the Company ) approved a share repurchase program (the Share Repurchase Program ), authorizing the purchase by the Company of up to $2.0 billion of the Company’s common stock ( Common Stock ) before March 9, 2027. On March 9, 2026, the Company entered into two accelerated share repurchase agreements (the ASR Agreements ) with Citibank, N.A. ( Citi ) to repurcha…
Results of Operations and Financial Condition. On February 25, 2026, United Therapeutics Corporation issued a press release setting forth its earnings and business updates for the quarter and year ended December 31, 2025. A copy of the press release is attached hereto as Exhibit 99.1.
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.